FDA commissioner watch intensifies as FDA reform bill nears completion.
This article was originally published in The Tan Sheet
Executive Summary
FDA COMMISSIONER WATCH INTENSIFIES: COMPLETION OF FDA REFORM BILL is a logical time for a White House nomination to be for-warded to the Senate for confirmation hearings. Any delays would suggest the nomination of HHS' preferred candidate, FDA Lead Deputy Commissioner Michael Friedman, MD, has run into roadblocks.